Legal Representation
Attorney
Eva Gullick Frongello
USPTO Deadlines
Next Deadline
1097 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230110)
Due Date
January 10, 2029
Grace Period Ends
July 10, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 10, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 10, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 21, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 21, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 21, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 1, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 1, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical research, namely, research relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical research, namely, research relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents
First Use Anywhere:
Jun 8, 2015
First Use in Commerce:
Jan 2, 2019
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"